The role of taxanes in the adjuvant treatment of early stage breast cancer.
- 1 March 2003
- journal article
- review article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 79 (1) , 25-34
- https://doi.org/10.1023/a:1024393926965
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Randomized Trial of Dose-Dense Versus Conventionally Scheduled and Sequential Versus Concurrent Combination Chemotherapy as Postoperative Adjuvant Treatment of Node-Positive Primary Breast Cancer: First Report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741Journal of Clinical Oncology, 2003
- Improved Outcomes From Adding Sequential Paclitaxel but Not From Escalating Doxorubicin Dose in an Adjuvant Chemotherapy Regimen for Patients With Node-Positive Primary Breast CancerJournal of Clinical Oncology, 2003
- Estimates of cancer incidence and mortality in Europe in 1995European Journal Of Cancer, 2002
- Cancer Statistics, 2002CA: A Cancer Journal for Clinicians, 2002
- Meeting Highlights: International Consensus Panel on the Treatment of Primary Breast CancerJournal of Clinical Oncology, 2001
- National Institutes of Health Consensus Development Conference Statement: Adjuvant Therapy for Breast Cancer, November 1-3, 2000JNCI Journal of the National Cancer Institute, 2001
- Polychemotherapy for early breast cancer: an overview of the randomised trialsThe Lancet, 1998
- Human pharmacokinetic characterization and in vitro study of the interaction between doxorubicin and paclitaxel in patients with breast cancer.Journal of Clinical Oncology, 1997
- Combined doxorubicin and paclitaxel in advanced breast cancer: Effective and cardiotoxicAnnals of Oncology, 1996
- Paclitaxel by 3-hour infusion in combination with bolus doxorubicin in women with untreated metastatic breast cancer: high antitumor efficacy and cardiac effects in a dose-finding and sequence-finding study.Journal of Clinical Oncology, 1995